The Alzheimer’s Association provides town hall meetings, action committees, fact sheets, and information on clinical trials.
Share and Enjoy:
A researcher at the University of Alberta was analyzing data from a Saskatchewan health database when she started to connect the dots between antidepressants and type 2 diabetes.
Lauren Brown, researcher, University of Alberta, studied the medical history of 2,400 people diagnosed with depression. She divided the people who were using antidepressants into one of 4 [...]
Dr. Beka Solomon, professor at the Tel Aviv University, wondered if Alzheimer’s disease could be treated through the nasal passage. Her logic was simple. One of the early Alzheimer’s disease signs is a loss of smell, because Alzheimer’s plaques first appear in the olfactory bulb.
She also realized that a harmless bacterial virus, known as ”filamentous phage”, [...]
A recent study found that Alzheimer’s patients have an elevated level of magnetic iron oxides in the area of the brain that is affected by the disease.
Jon Dobson, professor, Keele University, Staffordshire, UK, looked at the brain tissue from 11 Alzheimer’s disease patients and 11 age-matched control subjects. For the first time it shows that [...]
When occupational rehabilitation professionals consider when an employee should return to work they tend to emphasize the ability of a worker to perform tasks associated with their jobs.
Workers returning to their job after an injury are more likely to quit or be fired if their job requires more hours than the traditional 40-hour week. Allard Dembe, [...]
Pharmaceutical companies often distribute news releases about new drugs in clinical trials. Usually, there is a reference to a phase ranging from 1 to 4. Ever wonder what Phase II or Phase III clinical trials actually mean? This is a synopsis of the different types of clinical trials provided by the National Institutes of Health.
Phase I:
Study involves a [...]